Market Overview
The Global Varicella Zoster Infection Treatment Market was valued at USD 1.83 Billion in 2025 and is projected to reach USD 2.43 Billion by 2032, registering a CAGR of 4.12% from 2026 to 2032. Market development is supported by the growing geriatric population, continued prevalence of chickenpox and herpes zoster, increasing pharmaceutical activity, and advances in antiviral...